$AMGN
AMGEN INC Stock $amgn

$amgn Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000031815424000035 Filed on August 07, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$8.503B	$8.388B
YoY Change	23.18%	20.07%
Cost Of Revenue	$3.310B	$3.236B
YoY Change	83.28%	78.49%
Gross Profit	$5.193B	$5.152B
YoY Change	1.88%	-0.41%
Gross Profit Margin	61.07%	61.42%
Selling, General & Admin	$1.625B	$1.785B
YoY Change	20.1%	37.94%
% of Gross Profit	31.29%	34.65%
Research & Development	$1.450B	$1.447B
YoY Change	34.38%	30.01%
% of Gross Profit	27.92%	28.09%
Depreciation & Amortization	$1.396B	$1.400B
YoY Change	55.98%	56.25%
% of Gross Profit	26.88%	27.17%
Operating Expenses	$3.075B	$3.232B
YoY Change	26.44%	34.28%
Operating Profit	$2.047B	$1.909B
YoY Change	1.29%	-28.87%
Interest Expense	-$776.0M	-$1.206B
YoY Change	28.05%	60.37%
% of Operating Profit	-37.91%	-63.17%
Other Income/Expense, Net	$1.830B	-$307.0M
YoY Change	167.15%	-3.46%
Pretax Income	$3.101B	$794.0M
YoY Change	59.27%	-50.81%
Income Tax	$271.0M	$48.00M
% Of Pretax Income	8.74%	6.05%
Net Earnings	$2.830B	$746.0M
YoY Change	63.58%	-45.9%
Net Earnings / Revenue	33.28%	8.89%
Basic Earnings Per Share	$5.27	$1.39
Diluted Earnings Per Share	$5.22	$1.38
COMMON SHARES
Basic Shares Outstanding	537.3M shares	536.4M shares
Diluted Shares Outstanding	542.0M shares	541.0M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$9.011B	$9.301B
YoY Change	-74.03%	-72.8%
Cash & Equivalents	$9.011B	$9.301B
Short-Term Investments
Other Short-Term Assets	$3.076B	$2.976B
YoY Change	19.92%	28.06%
Inventory	$7.362B	$7.995B
Prepaid Expenses
Receivables	$7.317B	$6.934B
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$26.77B	$27.21B
YoY Change	-44.79%	-42.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.156B	$6.097B
YoY Change	10.66%	10.21%
Goodwill	$18.66B	$18.62B
YoY Change	20.3%	19.86%
Intangibles	$28.92B	$30.17B
YoY Change	119.92%	106.19%
Long-Term Investments
YoY Change
Other Assets	$10.38B	$8.816B
YoY Change	32.52%	22.56%
Total Long-Term Assets	$64.12B	$63.70B
YoY Change	52.45%	48.53%
TOTAL ASSETS
Total Short-Term Assets	$26.77B	$27.21B
Total Long-Term Assets	$64.12B	$63.70B
Total Assets	$90.88B	$90.91B
YoY Change	0.39%	0.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.147B	$2.267B
YoY Change	58.1%	87.05%
Accrued Expenses	$14.62B	$13.72B
YoY Change	3.2%	0.03%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.544B	$5.528B
YoY Change	148.18%	155.1%
Total Short-Term Liabilities	$20.31B	$21.52B
YoY Change	19.81%	25.85%
LONG-TERM LIABILITIES
Long-Term Debt	$56.85B	$57.12B
YoY Change	-3.7%	-3.81%
Other Long-Term Liabilities	$2.199B	$2.363B
YoY Change	-4.6%	-6.82%
Total Long-Term Liabilities	$59.05B	$59.48B
YoY Change	-3.74%	-3.93%
TOTAL LIABILITIES
Total Short-Term Liabilities	$20.31B	$21.52B
Total Long-Term Liabilities	$59.05B	$59.48B
Total Liabilities	$79.37B	$81.00B
YoY Change	1.36%	2.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.53B	-$27.12B
YoY Change	2.24%	6.2%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$7.527B	$5.925B
YoY Change
Total Liabilities & Shareholders Equity	$90.88B	$90.91B
YoY Change	0.39%	0.71%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$2.830B	$746.0M
YoY Change	63.58%	-45.9%
Depreciation, Depletion And Amortization	$1.396B	$1.400B
YoY Change	55.98%	56.25%
Cash From Operating Activities	$3.571B	$2.459B
YoY Change	29.38%	-40.16%
INVESTING ACTIVITIES
Capital Expenditures	$257.0M	$238.0M
YoY Change	3.63%	-12.18%
Acquisitions
YoY Change
Other Investing Activities	$47.00M	$21.00M
YoY Change	-435.71%	-65.0%
Cash From Investing Activities	-$210.0M	-$217.0M
YoY Change	-19.85%	2.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.651B	-2.649B
YoY Change	82.09%	118.93%
NET CHANGE
Cash From Operating Activities	3.571B	2.459B
Cash From Investing Activities	-210.0M	-217.0M
Cash From Financing Activities	-3.651B	-2.649B
Net Change In Cash	-290.0M	-407.0M
YoY Change	-158.82%	-115.14%
FREE CASH FLOW
Cash From Operating Activities	$3.571B	$2.459B
Capital Expenditures	$257.0M	$238.0M
Free Cash Flow	$3.314B	$2.221B
YoY Change	31.93%	-42.13%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	99000000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	35000000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3661000000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2841000000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-37000000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.13
CY2023Q1	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	1138000000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	47000000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	37000000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-12000000	usd
CY2024Q2	us-gaap	Goodwill Goodwill	18616000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	23806000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	31423000000	usd
CY2023Q4	amgn	Identifiable Intangible Assets Gross IdentifiableIntangibleAssetsGross	56447000000	usd
CY2023Q4	amgn	Identifiable Intangible Assets Accumulated Amortization IdentifiableIntangibleAssetsAccumulatedAmortization	23806000000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	32641000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	3000000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	119000000	usd
CY2023Q2	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	69000000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	16000000	usd
CY2023Q4	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://fasb.org/srt/2024#PartnershipInterestMember
CY2024Q2	us-gaap	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://fasb.org/srt/2024#PartnershipInterestMember
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6781000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	633000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4220000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2799000000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1796000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	260000000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	166000000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-784000000	usd
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-203000000	usd
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	39000000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-916000000	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	1169000000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	67000000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-5000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-310000000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	240000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1528000000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	28000000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	339000000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	69000000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	666000000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-371000000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-1311000000	usd
	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	471000000	usd
	amgn	Increase Decrease In Noncurrent Tax Liability IncreaseDecreaseInNoncurrentTaxLiability	-637000000	usd
	amgn	Increase Decrease In Noncurrent Tax Liability IncreaseDecreaseInNoncurrentTaxLiability	196000000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-361000000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	351000000	usd
	amgn	Increase Decrease In Sales Incentives And Allowance IncreaseDecreaseInSalesIncentivesAndAllowance	-393000000	usd
	amgn	Increase Decrease In Sales Incentives And Allowance IncreaseDecreaseInSalesIncentivesAndAllowance	173000000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-33000000	usd
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-122000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3148000000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	5173000000	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0	usd
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	1125000000	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	550000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	468000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	615000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-34000000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-87000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-434000000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	1147000000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	23780000000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	410000000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	420000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1400000000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	704000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2417000000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	2276000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-130000000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-81000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-4357000000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	20299000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1643000000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	26619000000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10944000000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7629000000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9301000000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34248000000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Use of estimates</span></div><div style="margin-bottom:8pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates.</span></div>
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10100000000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	9800000000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8388000000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6986000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	15835000000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13091000000	usd
CY2024Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.060
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.128
CY2023Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.146
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.165
CY2024Q2	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	40000000	usd
	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	80000000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	746000000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	1379000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	633000000	usd
	us-gaap	Net Income Loss NetIncomeLoss	4220000000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	537000000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	535000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	537000000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	534000000	shares
CY2024Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4000000	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	2000000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	4000000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	3000000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	541000000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	537000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	541000000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	537000000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.39
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.58
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	7.90
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.38
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.57
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.17
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.86
CY2024Q2	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	8812000000	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q2	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2024Q2	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	8812000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	10404000000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	10404000000	usd
CY2024Q2	us-gaap	Cash Cash	489000000	usd
CY2023Q4	us-gaap	Cash Cash	540000000	usd
CY2024Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	-50000000	usd
CY2023Q2	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	3000000	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	0	usd
CY2024Q2	amgn	Sale Of Equity Securities Fvni Unrealized Gain Loss SaleOfEquitySecuritiesFVNIUnrealizedGainLoss	0	usd
CY2023Q2	amgn	Sale Of Equity Securities Fvni Unrealized Gain Loss SaleOfEquitySecuritiesFVNIUnrealizedGainLoss	0	usd
	amgn	Sale Of Equity Securities Fvni Unrealized Gain Loss SaleOfEquitySecuritiesFVNIUnrealizedGainLoss	0	usd
	amgn	Sale Of Equity Securities Fvni Unrealized Gain Loss SaleOfEquitySecuritiesFVNIUnrealizedGainLoss	0	usd
	amgn	Increase And Decrease In Equity Securities Without Readily Determinable Fair Value Amount IncreaseAndDecreaseInEquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
CY2024Q2	amgn	Increase And Decrease In Equity Securities Without Readily Determinable Fair Value Amount IncreaseAndDecreaseInEquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
	amgn	Increase And Decrease In Equity Securities Without Readily Determinable Fair Value Amount IncreaseAndDecreaseInEquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
CY2023Q2	amgn	Increase And Decrease In Equity Securities Without Readily Determinable Fair Value Amount IncreaseAndDecreaseInEquitySecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
	amgn	Sale Of Securities Without Readily Determinable Fair Value Amount SaleOfSecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
CY2024Q2	amgn	Sale Of Securities Without Readily Determinable Fair Value Amount SaleOfSecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
CY2023Q2	amgn	Sale Of Securities Without Readily Determinable Fair Value Amount SaleOfSecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
	amgn	Sale Of Securities Without Readily Determinable Fair Value Amount SaleOfSecuritiesWithoutReadilyDeterminableFairValueAmount	0	usd
CY2024Q2	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	884000000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	993000000	usd
CY2024Q2	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	4476000000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	5747000000	usd
CY2024Q2	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2635000000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2778000000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	7995000000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	9518000000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	18629000000	usd
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-1000000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-12000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	55071000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26049000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	29022000000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	55229000000	usd
CY2024Q2	amgn	Identifiable Intangible Assets Gross IdentifiableIntangibleAssetsGross	56221000000	usd
CY2024Q2	amgn	Identifiable Intangible Assets Accumulated Amortization IdentifiableIntangibleAssetsAccumulatedAmortization	26049000000	usd
CY2024Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	30172000000	usd
CY2024Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1200000000	usd
CY2023Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	693000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2400000000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	2400000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	4500000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	3900000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	3900000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	2900000000	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	2200000000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1389000000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	1420000000	usd
CY2024Q2	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	-345000000	usd
CY2023Q4	us-gaap	Hedged Liability Fair Value Hedge Cumulative Increase Decrease HedgedLiabilityFairValueHedgeCumulativeIncreaseDecrease	-314000000	usd
CY2024Q2	us-gaap	Other Long Term Debt OtherLongTermDebt	29000000	usd
CY2023Q4	us-gaap	Other Long Term Debt OtherLongTermDebt	17000000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	62645000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	64613000000	usd
CY2024Q2	us-gaap	Long Term Debt Current LongTermDebtCurrent	5528000000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1443000000	usd
CY2024Q2	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	57117000000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	63170000000	usd
CY2024Q2	us-gaap	Extinguishment Of Debt Amount ExtinguishmentOfDebtAmount	410000000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	133000000	usd
CY2024Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	7000000000.0	usd
CY2023Q4	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.25
CY2024Q2	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.25
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	2.25
CY2024Q1	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	2.25
CY2024Q2	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	3470000000	usd
CY2024Q2	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	12552000000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	107000000	usd
CY2024Q2	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1134000000	usd
CY2023Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	4514000000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	15063000000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	96000000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	1188000000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	96000000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	273000000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	96000000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	270000000	usd
CY2024Q2	amgn	Business Combination Contingent Consideration Arrangements Payments BusinessCombinationContingentConsiderationArrangementsPayments	2000000	usd
CY2023Q2	amgn	Business Combination Contingent Consideration Arrangements Payments BusinessCombinationContingentConsiderationArrangementsPayments	2000000	usd
	amgn	Business Combination Contingent Consideration Arrangements Payments BusinessCombinationContingentConsiderationArrangementsPayments	4000000	usd
	amgn	Business Combination Contingent Consideration Arrangements Payments BusinessCombinationContingentConsiderationArrangementsPayments	4000000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	13000000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-23000000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	15000000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-18000000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	107000000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	248000000	usd
CY2024Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	107000000	usd
CY2023Q2	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	248000000	usd
CY2024Q2	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	59300000000	usd
CY2023Q4	us-gaap	Notes Payable Fair Value Disclosure NotesPayableFairValueDisclosure	59200000000	usd
CY2024Q2	us-gaap	Long Term Debt LongTermDebt	62600000000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	64600000000	usd
	us-gaap	Maximum Length Of Time Foreign Currency Cash Flow Hedge MaximumLengthOfTimeForeignCurrencyCashFlowHedge	P3Y
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-307000000	usd
CY2024Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	808000000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-542000000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1632000000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-318000000	usd
CY2023Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	752000000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1746000000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	1295000000	usd
CY2024Q2	us-gaap	Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months	119000000	usd
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	270000000	usd
CY2024Q2	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1027000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	145000000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1092000000	usd
CY2024Q2	amgn	Number Of Securities Cases Filed NumberOfSecuritiesCasesFiled	2	securitycase
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000318154-24-000035-index-headers.html	Edgar Link	pending
0000318154-24-000035-index.html	Edgar Link	pending
0000318154-24-000035.txt	Edgar Link	pending
0000318154-24-000035-xbrl.zip	Edgar Link	pending
amgn-20240630.htm	Edgar Link	pending
amgn-20240630.xsd	Edgar Link	pending
amgn-ex31_20240630x10xq.htm	Edgar Link	pending
amgn-ex32_20240630x10xq.htm	Edgar Link	pending
exhibit102-formofgrantstoc.htm	Edgar Link	pending
exhibit103-formofrestricte.htm	Edgar Link	pending
exhibit104-amgeninc2009per.htm	Edgar Link	pending
exhibit105-formofperforman.htm	Edgar Link	pending
exhibit106-amgeninc2009dir.htm	Edgar Link	pending
exhibit107-formofrestricte.htm	Edgar Link	pending
exhibit108-formofcashxsett.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_1a.jpg	Edgar Link	pending
image_1c.jpg	Edgar Link	pending
image_1d.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
amgn-20240630_def.xml	Edgar Link	unprocessable
amgn-20240630_lab.xml	Edgar Link	unprocessable
amgn-20240630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
amgn-20240630_htm.xml	Edgar Link	completed
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
amgn-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMGN
AMGEN INC Stock $amgn

2024 Q3 Form 10-Q Financial Statement

#000031815424000035 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMGN AMGEN INC Stock $amgn

2024 Q3 Form 10-Q Financial Statement

#000031815424000035 Filed on August 07, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMGN
AMGEN INC Stock $amgn